Yahoo
OTC Markets OTCPK - Delayed Quote USD

Nutra Pharma Corp. (NPHC)

0.0001 0.0000 (0.00%)
At close: 3:21:49 PM EST
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Total Revenue
258.9060
385.3070
392.1500
594.8800
438.2740
Cost of Revenue
133.2370
188.6790
144.8270
198.4250
189.2520
Gross Profit
125.6690
196.6280
247.3230
396.4550
249.0220
Operating Expense
1,762.3720
1,658.9660
1,125.7440
1,177.9690
2,084.6300
Operating Income
-1,636.7030
-1,462.3380
-878.4210
-781.5140
-1,835.6080
Net Non Operating Interest Income Expense
-446.0050
-440.0600
-323.5680
-399.7590
-791.4830
Other Income Expense
-3,337.7850
-144.9940
-83.6740
-212.0830
10,803.9620
Pretax Income
-5,420.4930
-2,047.3920
-1,285.6630
-1,393.3560
8,176.8710
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-5,420.4930
-2,047.3920
-1,285.6630
-1,393.3560
8,176.8710
Average Dilution Earnings
--
--
--
0
-522.2230
Diluted NI Available to Com Stockholders
-5,420.4930
-2,047.3920
-1,285.6630
-1,393.3560
7,654.6480
Basic EPS
0.00
0.00
0.00
0.00
0.00
Diluted EPS
0.00
0.00
0.00
0.00
0.00
Basic Average Shares
7,943,386.0260
7,778,855.6390
7,673,659.5910
7,607,513.1730
7,502,851.8030
Diluted Average Shares
7,943,386.0260
7,778,855.6390
7,673,659.5910
7,607,513.1730
19,096,539.3080
Total Operating Income as Reported
-1,636.7030
-1,462.3380
-878.4210
-886.9790
-1,907.4040
Total Expenses
1,895.6090
1,847.6450
1,270.5710
1,376.3940
2,273.8820
Net Income from Continuing & Discontinued Operation
-5,420.4930
-2,047.3920
-1,285.6630
-1,393.3560
8,176.8710
Normalized Income
-2,080.4030
-1,843.6480
-1,098.5390
-1,108.2120
-2,610.8760
Interest Expense
446.0050
440.0600
323.5680
399.7590
791.4830
Net Interest Income
-446.0050
-440.0600
-323.5680
-399.7590
-791.4830
EBIT
-4,974.4880
-1,607.3320
-962.0950
-993.5970
8,968.3540
EBITDA
-4,917.9670
-1,505.9000
-870.9160
-897.9800
9,084.8460
Reconciled Cost of Revenue
133.2370
188.6790
144.8270
198.4250
189.2520
Reconciled Depreciation
56.5210
101.4320
91.1790
95.6170
116.4920
Net Income from Continuing Operation Net Minority Interest
-5,420.4930
-2,047.3920
-1,285.6630
-1,393.3560
8,176.8710
Total Unusual Items Excluding Goodwill
-3,340.0900
-203.7440
-187.1240
-285.1440
10,787.7470
Total Unusual Items
-3,340.0900
--
--
--
--
Normalized EBITDA
-1,577.8770
-1,302.1560
-683.7920
-612.8360
-1,702.9010
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2022 - 12/6/2001

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: